Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivityKarolina Lindberg, Lars‐Arne Haldosén|Breast Cancer Research|2011Cited by 79